Drugs Made In America Acquisition II Corp. (DMIIR)
DMIIR Stock Price Chart
Explore Drugs Made In America Acquisition II Corp. interactive price chart. Choose custom timeframes to analyze DMIIR price movements and trends.
DMIIR Company Profile
Discover essential business fundamentals and corporate details for Drugs Made In America Acquisition II Corp. (DMIIR) to support your stock research and investment decisions.
Sector
Financial Services
Industry
Financial - Conglomerates
IPO Date
4 Dec 2025
Employees
—
Website
https://dmaacorp.com/CEO
Roger Bendelac
Description
Drugs Made In America Acquisition II Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The company was founded on August 23, 2024 and is headquartered in Fort Lauderdale, FL.
DMIIR Financial Timeline
Browse a chronological timeline of Drugs Made In America Acquisition II Corp. corporate events including earnings releases, dividend announcements, and stock splits.
DMIIR Stock Performance
Access detailed DMIIR performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
